Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Recent Advances in Herpesviruses Research: What's in the Pipeline?"
Deadline for manuscript submissions: 31 October 2019.
Dr. Sherif T. S. Hassan Website E-Mail
Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého tř. 1946/1, 612 42 Brno, Czech Republic
Interests: pharmacology and toxicology; molecular mechanisms of pharmacological action; natural products chemistry; infectious diseases
In recent years, infection with herpesviruses has become a global concern due to its great threat to public health. Herpesviruses are infectious agents belonging to the virus family Herpesviridae that cause latent and lytic infections in humans and in a wide range of animals. There are eight herpesvirus types currently known to infect humans, including Herpes simplex viruses (HSV-1 and HSV-2), varicella-zoster virus, Epstein–Barr virus, human herpesvirus 6 (variants A and B), human herpesvirus 7, Kaposi's sarcoma-associated herpesvirus, and human cytomegalovirus. Although the efficacy of the treatments of herpesviruses infection has improved during the past two decades, the increasing use of antiviral drugs has resulted in drug resistance, which, in turn, has switched researchers’ attention toward more effective therapeutic strategies based on novel antiviral drugs associated with decreased resistance, less undesirable side effects, and various mechanisms of action. This Special Issue aims to shed light on the recent advances in both preclinical and clinical studies on herpesviruses and in therapeutic developments in the treatment of herpesviruses infection.Dr. Sherif T. S. Hassan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- herpesviruses infection
- antiviral therapeutics
- vaccine development
- preclinical and clinical studies
- host–pathogen interactions
- viral pathogenesis